Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | Director | Jan 29, 2023 | Option Exercise | $1.50 | 140 | 210 | 14,283 | Jan 31, 2023, 08:56 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Director | Jan 29, 2023 | Option Exercise | $1.50 | 431 | 647 | 11,989 | Jan 31, 2023, 08:55 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Jan 06, 2023 | Option Exercise | $1.30 | 5 | 6 | 14,423 | Jan 10, 2023, 05:58 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jan 06, 2023 | Option Exercise | $1.30 | 11 | 14 | 12,420 | Jan 10, 2023, 05:56 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Dec 31, 2022 | Option Exercise | $1.89 | 5 | 9 | 12,431 | Jan 04, 2023, 06:09 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Dec 31, 2022 | Option Exercise | $1.89 | 3 | 6 | 14,428 | Jan 04, 2023, 06:08 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Dec 06, 2022 | Option Exercise | $2.02 | 4 | 8 | 14,431 | Dec 08, 2022, 04:37 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Dec 06, 2022 | Option Exercise | $2.02 | 9 | 18 | 12,436 | Dec 08, 2022, 04:34 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Nov 30, 2022 | Option Exercise | $2.25 | 3 | 7 | 14,435 | Dec 02, 2022, 05:17 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Nov 30, 2022 | Option Exercise | $2.25 | 5 | 11 | 12,445 | Dec 02, 2022, 05:15 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Nov 06, 2022 | Option Exercise | $2.24 | 4 | 9 | 14,438 | Nov 08, 2022, 05:26 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Nov 06, 2022 | Option Exercise | $2.24 | 10 | 22 | 12,450 | Nov 08, 2022, 05:24 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Oct 31, 2022 | Option Exercise | $2.54 | 5 | 13 | 12,460 | Nov 01, 2022, 05:08 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Oct 31, 2022 | Option Exercise | $2.54 | 3 | 8 | 14,442 | Nov 01, 2022, 05:06 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Oct 06, 2022 | Option Exercise | $2.72 | 9 | 24 | 12,465 | Oct 11, 2022, 05:03 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Oct 06, 2022 | Option Exercise | $2.72 | 4 | 11 | 14,445 | Oct 11, 2022, 05:00 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Sep 30, 2022 | Option Exercise | $2.08 | 3 | 6 | 14,449 | Oct 04, 2022, 09:36 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Sep 30, 2022 | Option Exercise | $2.08 | 5 | 10 | 12,474 | Oct 04, 2022, 09:31 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Sep 06, 2022 | Option Exercise | $0.16 | 225 | 35 | 311,977 | Sep 07, 2022, 06:00 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Sep 06, 2022 | Option Exercise | $0.16 | 89 | 14 | 361,311 | Sep 07, 2022, 05:57 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Aug 31, 2022 | Option Exercise | $0.16 | 107 | 18 | 312,202 | Sep 01, 2022, 06:38 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Aug 31, 2022 | Option Exercise | $0.16 | 61 | 10 | 361,400 | Sep 01, 2022, 06:35 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Aug 06, 2022 | Option Exercise | $0.18 | 89 | 16 | 361,461 | Aug 08, 2022, 05:45 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Aug 06, 2022 | Option Exercise | $0.18 | 225 | 42 | 312,309 | Aug 08, 2022, 05:44 PM | |
NBRV | Nabriva Therapeutics plc | BURGESS DANIEL D | Director | Aug 02, 2022 | Sale | $0.19 | 11,341 | 2,156 | 10,384 | Aug 04, 2022, 06:24 PM | |
NBRV | Nabriva Therapeutics plc | Broom Colin MD | Director | Aug 02, 2022 | Sale | $0.19 | 5,339 | 1,015 | 36,523 | Aug 04, 2022, 06:22 PM | |
NBRV | Nabriva Therapeutics plc | Webster Stephen W | Director | Aug 02, 2022 | Sale | $0.19 | 7,826 | 1,487 | 11,447 | Aug 04, 2022, 06:20 PM | |
NBRV | Nabriva Therapeutics plc | CORRIGAN MARK | Director | Aug 02, 2022 | Sale | $0.19 | 10,297 | 1,956 | 7,203 | Aug 04, 2022, 06:19 PM | |
NBRV | Nabriva Therapeutics plc | Rowland Charles A Jr | Director | Aug 01, 2022 | Sale | $0.17 | 8,496 | 1,487 | 15,277 | Aug 03, 2022, 09:48 PM | |
NBRV | Nabriva Therapeutics plc | Bourdow Carrie L. | Director | Aug 01, 2022 | Sale | $0.17 | 8,540 | 1,487 | 9,933 | Aug 03, 2022, 09:47 PM | |
NBRV | Nabriva Therapeutics plc | Dalton Lisa | Director | Jul 31, 2022 | Option Exercise | $0.18 | 8,400 | 1,504 | 9,100 | Aug 03, 2022, 09:46 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jul 31, 2022 | Option Exercise | $0.18 | 107 | 19 | 312,534 | Aug 03, 2022, 09:45 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Jul 31, 2022 | Option Exercise | $0.18 | 61 | 11 | 361,550 | Aug 03, 2022, 09:43 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jul 06, 2022 | Option Exercise | $0.18 | 225 | 41 | 312,641 | Jul 07, 2022, 04:11 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Jul 06, 2022 | Option Exercise | $0.18 | 89 | 16 | 361,611 | Jul 07, 2022, 04:10 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jun 30, 2022 | Option Exercise | $0.18 | 107 | 19 | 312,866 | Jul 01, 2022, 06:08 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Jun 30, 2022 | Option Exercise | $0.18 | 61 | 11 | 361,700 | Jul 01, 2022, 06:06 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jun 06, 2022 | Option Exercise | $0.20 | 225 | 45 | 312,973 | Jun 07, 2022, 04:47 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Jun 06, 2022 | Option Exercise | $0.20 | 89 | 18 | 361,761 | Jun 07, 2022, 04:46 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | May 31, 2022 | Option Exercise | $0.21 | 107 | 22 | 313,198 | Jun 02, 2022, 04:10 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | May 31, 2022 | Option Exercise | $0.21 | 61 | 13 | 361,850 | Jun 02, 2022, 04:09 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | May 06, 2022 | Option Exercise | $0.26 | 89 | 23 | 361,911 | May 09, 2022, 06:33 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | May 06, 2022 | Option Exercise | $0.26 | 225 | 58 | 313,305 | May 09, 2022, 06:32 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Apr 30, 2022 | Option Exercise | $0.31 | 107 | 33 | 313,530 | May 03, 2022, 04:59 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Apr 30, 2022 | Option Exercise | $0.31 | 61 | 19 | 362,000 | May 03, 2022, 04:58 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Apr 06, 2022 | Option Exercise | $0.41 | 219 | 90 | 313,637 | Apr 08, 2022, 04:16 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Apr 06, 2022 | Option Exercise | $0.41 | 89 | 36 | 362,061 | Apr 08, 2022, 04:15 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Mar 31, 2022 | Option Exercise | $0.42 | 104 | 44 | 313,856 | Apr 04, 2022, 06:27 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Mar 31, 2022 | Option Exercise | $0.42 | 61 | 26 | 362,150 | Apr 04, 2022, 06:26 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Mar 06, 2022 | Option Exercise | $0.43 | 89 | 38 | 362,211 | Mar 08, 2022, 04:14 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Mar 06, 2022 | Option Exercise | $0.43 | 263 | 113 | 313,960 | Mar 08, 2022, 04:12 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Feb 28, 2022 | Option Exercise | $0.45 | 125 | 56 | 314,223 | Mar 02, 2022, 07:51 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Feb 28, 2022 | Option Exercise | $0.45 | 61 | 27 | 362,300 | Mar 02, 2022, 07:50 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Feb 06, 2022 | Option Exercise | $0.48 | 106 | 51 | 362,361 | Feb 08, 2022, 04:26 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Feb 06, 2022 | Option Exercise | $0.48 | 263 | 126 | 314,348 | Feb 08, 2022, 04:25 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jan 29, 2022 | Option Exercise | $0.45 | 10,766 | 4,845 | 314,736 | Feb 01, 2022, 08:47 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jan 31, 2022 | Option Exercise | $0.48 | 125 | 60 | 314,611 | Feb 01, 2022, 08:47 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Jan 29, 2022 | Option Exercise | $0.45 | 3,483 | 1,567 | 362,540 | Feb 01, 2022, 08:44 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Jan 31, 2022 | Option Exercise | $0.48 | 73 | 35 | 362,467 | Feb 01, 2022, 08:44 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jan 06, 2022 | Option Exercise | $0.58 | 270 | 157 | 325,502 | Jan 10, 2022, 04:19 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Jan 06, 2022 | Option Exercise | $0.58 | 110 | 64 | 366,023 | Jan 10, 2022, 04:18 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Dec 28, 2021 | Buy | $0.57 | 100,000 | 57,320 | 325,879 | Dec 29, 2021, 09:32 PM | |
NBRV | Nabriva Therapeutics plc | Naftzger J. Christopher | General Counsel and Corp Sec | Dec 27, 2021 | Buy | $0.59 | 7,000 | 4,130 | 7,000 | Dec 28, 2021, 07:04 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Dec 06, 2021 | Option Exercise | $0.72 | 225 | 162 | 225,879 | Dec 08, 2021, 05:14 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Dec 06, 2021 | Option Exercise | $0.72 | 92 | 66 | 366,196 | Dec 08, 2021, 05:13 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Nov 30, 2021 | Option Exercise | $0.78 | 107 | 83 | 226,104 | Dec 02, 2021, 06:31 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Nov 30, 2021 | Option Exercise | $0.78 | 63 | 49 | 366,288 | Dec 02, 2021, 06:28 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Nov 06, 2021 | Option Exercise | $1.33 | 225 | 299 | 226,211 | Nov 09, 2021, 05:38 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Nov 06, 2021 | Option Exercise | $1.33 | 92 | 122 | 366,351 | Nov 09, 2021, 05:36 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Oct 31, 2021 | Option Exercise | $1.15 | 107 | 123 | 226,436 | Nov 01, 2021, 07:51 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Oct 31, 2021 | Option Exercise | $1.15 | 63 | 72 | 366,443 | Nov 01, 2021, 07:50 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Oct 06, 2021 | Option Exercise | $1.08 | 92 | 99 | 366,506 | Oct 08, 2021, 04:41 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Oct 06, 2021 | Option Exercise | $1.08 | 225 | 243 | 226,543 | Oct 08, 2021, 04:39 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Sep 30, 2021 | Option Exercise | $1.19 | 107 | 127 | 226,768 | Oct 04, 2021, 04:14 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Sep 30, 2021 | Option Exercise | $1.19 | 63 | 75 | 366,598 | Oct 04, 2021, 04:09 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Sep 14, 2021 | Buy | $1.13 | 50,000 | 56,500 | 226,875 | Sep 15, 2021, 08:00 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Sep 06, 2021 | Option Exercise | $1.11 | 225 | 250 | 176,875 | Sep 08, 2021, 05:27 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Sep 06, 2021 | Option Exercise | $1.11 | 93 | 103 | 366,661 | Sep 08, 2021, 05:25 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Aug 31, 2021 | Option Exercise | $1.06 | 63 | 67 | 366,754 | Sep 02, 2021, 04:09 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Aug 31, 2021 | Option Exercise | $1.06 | 107 | 113 | 177,100 | Sep 02, 2021, 04:07 PM | |
NBRV | Nabriva Therapeutics plc | Crotty Robert | Gen Counsel & Corp Secretary | Aug 31, 2021 | Option Exercise | $1.06 | 37 | 39 | 41,194 | Sep 02, 2021, 04:06 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Aug 06, 2021 | Option Exercise | $1.17 | 225 | 263 | 177,207 | Aug 10, 2021, 05:16 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Aug 06, 2021 | Option Exercise | $1.17 | 92 | 108 | 366,817 | Aug 10, 2021, 05:15 PM | |
NBRV | Nabriva Therapeutics plc | Crotty Robert | Gen Counsel & Corp Secretary | Aug 06, 2021 | Option Exercise | $1.17 | 74 | 87 | 41,231 | Aug 10, 2021, 05:13 PM | |
NBRV | Nabriva Therapeutics plc | Webster Stephen W | Director | Aug 02, 2021 | Sale | $1.20 | 777 | 932 | 19,273 | Aug 04, 2021, 09:08 PM | |
NBRV | Nabriva Therapeutics plc | BURGESS DANIEL D | Director | Aug 02, 2021 | Sale | $1.20 | 1,125 | 1,350 | 21,725 | Aug 04, 2021, 09:07 PM | |
NBRV | Nabriva Therapeutics plc | Broom Colin MD | Director | Aug 02, 2021 | Sale | $1.20 | 531 | 637 | 41,862 | Aug 04, 2021, 09:06 PM | |
NBRV | Nabriva Therapeutics plc | Rowland Charles A Jr | Director | Aug 02, 2021 | Sale | $1.20 | 777 | 932 | 23,773 | Aug 04, 2021, 09:05 PM | |
NBRV | Nabriva Therapeutics plc | Bourdow Carrie L. | Director | Aug 02, 2021 | Sale | $1.20 | 777 | 932 | 18,473 | Aug 04, 2021, 09:04 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jul 31, 2021 | Option Exercise | $1.10 | 107 | 118 | 177,432 | Aug 03, 2021, 04:09 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Jul 31, 2021 | Option Exercise | $1.10 | 63 | 69 | 366,909 | Aug 03, 2021, 04:07 PM | |
NBRV | Nabriva Therapeutics plc | Crotty Robert | Gen Counsel & Corp Secretary | Jul 31, 2021 | Option Exercise | $1.10 | 37 | 41 | 41,305 | Aug 03, 2021, 04:06 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jul 06, 2021 | Option Exercise | $1.27 | 225 | 286 | 177,539 | Jul 08, 2021, 04:11 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Jul 06, 2021 | Option Exercise | $1.27 | 92 | 117 | 366,972 | Jul 08, 2021, 04:09 PM | |
NBRV | Nabriva Therapeutics plc | Crotty Robert | Gen Counsel & Corp Secretary | Jul 06, 2021 | Option Exercise | $1.27 | 74 | 94 | 41,342 | Jul 08, 2021, 04:09 PM | |
NBRV | Nabriva Therapeutics plc | Schroeder Theodore R | Chief Executive Officer | Jun 30, 2021 | Option Exercise | $1.35 | 107 | 144 | 177,764 | Jul 02, 2021, 04:06 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Jun 30, 2021 | Option Exercise | $1.35 | 63 | 85 | 367,064 | Jul 02, 2021, 04:05 PM | |
NBRV | Nabriva Therapeutics plc | Crotty Robert | Gen Counsel & Corp Secretary | Jun 30, 2021 | Option Exercise | $1.35 | 37 | 50 | 41,416 | Jul 02, 2021, 04:04 PM | |
NBRV | Nabriva Therapeutics plc | Gelone Steven P. | President and COO | Jun 06, 2021 | Option Exercise | $1.34 | 92 | 123 | 367,127 | Jun 08, 2021, 04:09 PM | |
NBRV | Nabriva Therapeutics plc | Crotty Robert | Gen Counsel & Corp Secretary | Jun 06, 2021 | Option Exercise | $1.34 | 73 | 98 | 41,453 | Jun 08, 2021, 04:05 PM |